Newsfeeds - Spark Newswire

1 minute read

Raymond James Initiates Coverage On POINT Biopharma Global with Outperform Rating, Announces Price Target of $10

December 14, 9:19 AM

Raymond James analyst Rahul Sarugaser initiates coverage on POINT Biopharma Global (NASDAQ:PNT) with a Outperform rating and announces Price Target of $10.

PNT

2 minute read

Analyst Ratings

Analyst Ratings for POINT Biopharma Global

By Benzinga Insights

November 15, 12:47 PM

Over the past 3 months, 5 analysts have published their opinion on POINT Biopharma Global (NASDAQ:PNT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

PNT

3 minute read

Dow Surges 150 Points; Crude Oil Falls Sharply

By Lisa Levin

November 14, 3:34 PM

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones gaining around 150 points on Monday.

FRGT

4 minute read

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

November 14, 2:05 PM

Gainers Freight Technologies, Inc. (NASDAQ: FRGT) shares surged 137% to $0.4901 after analysts at Chardan Capital initiated coverage of the stock with a $2.25 price target.

AGEN

3 minute read

US Stocks Mostly Lower; Nasdaq Drops Over 100 Points

By Lisa Levin

November 14, 11:38 AM

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Monday.

ARDX

4 minute read

News

Lantheus And POINT Biopharma Announce Strategic Collaboration And Exclusive License Agreements For The Commercialization Of PNT2002 & PNT2003

By Benzinga Newsdesk

November 14, 8:20 AM

Lantheus Holdings, Inc. (”Lantheus”) (NASDAQ:LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to

LNTH

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

September 27, 5:44 PM

Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.

ANPC

5 minute read

Why Vintage Wine Estates Shares Tumbled 40%; Here Are 70 Biggest Movers From Yesterday

By Lisa Levin

September 15, 5:21 AM

Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as the stock experienced a resurgence in momentum despite a lack of fundamental news.

1 minute read

Nucor, Altimmune And Some Other Big Stocks Moving Lower On Wednesday

By Lisa Levin

September 14, 11:04 AM

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Wednesday. Here are some big stocks recording losses in today’s session.

1 minute read

Movers

Why POINT Biopharma Shares Are Getting Hammered

By Henry Khederian

September 14, 10:47 AM

POINT Biopharma Global Inc (NASDAQ: PNT) shares are trading lower by 11.41% to $9.01 Wednesday morning after the company priced a public offering of 13.9 million shares of common stock at $9 per share. What Else?

PNT